Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Chronically infected mice show elevated antibody levels after infection with clinical strains of B. pseudomallei

From: Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei

Groupb

 

Antibody Titera

 

Ratio

 

IgG

IgG1

IgG2a

IgG2a/IgG1

Gp. 1. Naïve (10)

50 (1.00)c

50 (1.00)c

50 (1.00)c

1.00

Gp. 2. Normal Appearing (32)e

58 (1.10)

53 (1.05)

50 (1.00)c

0.94

Gp. 3. Swollen (8)e

28,537 (2.45) P = 0.0002d

10,089 (2.12) P = 0.0002d

22,307 (3.17) P = 0.0019d

2.21

Gp. 4. Chronically Infected(23)e

201,364 (1.24) P < 0.0001d

68,046 (1.33) P < 0.0001d

82,328 (1.34) P < 0.0001d

1.21

  1. a Antibody titers were done in triplicate for each mouse at least once, and titers are reported as geometric mean with geometric SEM
  2. b There was a total of 63 sera from exposed BALB/c mice. The number in parentheses represents the number of mice in each group
  3. c The number 50 was used for calculation of statistics although the antibody titers were less than 50
  4. d The significant levels are derived from comparing antibody levels for specific groups with those of naïve (Gp 1) mice
  5. e The exposure strain and number of mice (in parenthesis) in each group as follows: Gp. 2, MSHR5855 (7), HBPUB10134a (8), 406e (3), MSHR668 (5), MSHR5848 (6), K96243 (3); Gp. 3, 406e (1), 1026b (1), MSHR668 (1), MSHR5848 (1), MSHR305 (1), K96243 (1), 1106a (2); Gp. 4, MSHR5855 (1), 406e (2), 1026b (3), MSHR668 (1), MSHR5848 (1), MSHR5858 (4), MSHR305 (3), K96243 (2), 1106a (6)
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us